{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-053816","form_type":"8-K","ticker":"MRNA","cik":"0001682852","company_name":"Moderna, Inc.","filed_at":"2025-11-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.140578+00:00","generated_at":"2026-05-16T17:19:48.290606+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Moderna enters $1.5B credit facility with Ares; $600M initial term loan, $900M delayed draw","bullets":["$1.5B facility: $600M initial term loan and $900M delayed draw tranche available through Nov 2027/2028.","Interest at Term SOFR + 5.50% or base rate + 4.50%; maturity date November 24, 2030.","Secured by all assets of Moderna; guaranteed by US, Canadian, UK, Swiss, and Australian subsidiaries.","Minimum liquidity covenant of $500M ($750M if >$1B drawn); not tested if market cap >$5B.","Proceeds used for general corporate purposes; loan contingent on regulatory milestones for delayed draw portion."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-053816","json":"https://secwatch.observer/filing/0001628280-25-053816.json","markdown":"https://secwatch.observer/filing/0001628280-25-053816.md","text":"https://secwatch.observer/filing/0001628280-25-053816.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1682852/000162828025053816/0001628280-25-053816-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1682852/000162828025053816/mrna-20251119.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T17:19:48.290606+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f37f76587edda67ea51f04aa5e44be6b0e792af8","claim":"Moderna, Inc. incurred credit facility of $1,500,000,000 credit facility with Ares Capital Corporation at Term SOFR plus an applicable margin of 5.50% per annum or base rate plus an appl maturing November 24, 2030.","evidence_excerpt":"The Credit Agreement provides for a $1,500,000,000 credit facility of which $600,000,000 will be funded as an initial term loan and $900,000,000 will be available as delayed draw term loans.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1682852/000162828025053816/0001628280-25-053816-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"credit facility"},{"label":"Principal","value":"$1,500,000,000 credit facility"},{"label":"Counterparty","value":"Ares Capital Corporation"},{"label":"Rate","value":"Term SOFR plus an applicable margin of 5.50% per annum or base rate plus an appl"},{"label":"Maturity","value":"November 24, 2030"},{"label":"Event","value":"incurrence"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}